monocytes/macrophages kinase promotes rheumatoid arthritis through activation of Signaling of vascular endothelial growth factor receptor-1 tyrosine
暂无分享,去创建一个
[1] M. Shibuya,et al. KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth. , 2004, Molecular cancer therapeutics.
[2] I. McInnes,et al. Targeting cytokines beyond tumor necrosis factor-α and interleukin-1 in rheumatoid arthritis , 2004 .
[3] P. Bohlen,et al. Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis 1 , 2003, The Journal of Immunology.
[4] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[5] J. Haigh,et al. Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. , 2003, The Journal of clinical investigation.
[6] M. Shibuya,et al. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. , 2002, Cancer cell.
[7] A. Luttun,et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.
[8] S. Rafii,et al. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment , 2002, Nature Medicine.
[9] Y. Iwakura,et al. Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. , 2002, Arthritis and rheumatism.
[10] Till Acker,et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.
[11] M. Shibuya. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). , 2001, The international journal of biochemistry & cell biology.
[12] T. Noda,et al. Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis. , 2001, Cancer research.
[13] M. Shibuya. Structure and function of VEGF/VEGF-receptor system involved in angiogenesis. , 2001, Cell structure and function.
[14] K. Shitara,et al. and surface marker for the lineage of monocyte-macrophages in humans Flt-1 , vascular endothelial growth factor receptor 1 , is a novel cell , 2001 .
[15] P. Hirth,et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. , 2000, The Journal of clinical investigation.
[16] M. Shibuya,et al. VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells , 1999, Oncogene.
[17] Y. Iwakura,et al. The human T cell leukemia virus type I-tax gene is responsible for the development of both inflammatory polyarthropathy resembling rheumatoid arthritis and noninflammatory ankylotic arthropathy in transgenic mice. , 1999, Journal of immunology.
[18] A. Ullrich,et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. , 1999, Cancer research.
[19] S. Ueda,et al. The development of autoimmune inflammatory arthropathy in mice transgenic for the human T cell leukemia virus type-1 env-pX region is not dependent on H-2 haplotypes and modified by the expression levels of Fas antigen. , 1998, Journal of immunology.
[20] Vishva Dixit,et al. Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.
[21] T. Noda,et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[22] M. Toyoda,et al. Differential inhibition of fluid accumulation and tumor growth in two mouse ascites tumors by an antivascular endothelial growth factor/permeability factor neutralizing antibody. , 1998, Cancer research.
[23] M. Shibuya,et al. Genomic organization of the flt-1 gene encoding for vascular endothelial growth factor (VEGF) receptor-1 suggests an intimate evolutionary relationship between the 7-Ig and the 5-Ig tyrosine kinase receptors. , 1998, Gene.
[24] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[25] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[26] G. Breier,et al. The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities , 1996, The Journal of Biological Chemistry.
[27] A. Mantovani,et al. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. , 1996, Blood.
[28] M. Shibuya,et al. Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[29] Y. Kanai,et al. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans. , 1995, Journal of immunology.
[30] J. Rossant,et al. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.
[31] Janet Rossant,et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.
[32] K. Alitalo,et al. Endothelial receptor tyrosine kinases involved in angiogenesis , 1995, The Journal of cell biology.
[33] M. Shibuya,et al. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. , 1995, Oncogene.
[34] M. Shibuya,et al. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). , 1994, Oncogene.
[35] N. Olsen,et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue , 1994, The Journal of experimental medicine.
[36] G. Haines,et al. Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. , 1994, Journal of immunology.
[37] K. Alitalo,et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells , 1993, The Journal of experimental medicine.
[38] C. Marcelle,et al. Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development , 1993, Mechanisms of Development.
[39] G. Firestein. Mechanisms of tissue destruction and cellular activation in rheumatoid arthritis. , 1992, Current opinion in rheumatology.
[40] J. Winer,et al. Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. , 1992, The Journal of clinical investigation.
[41] al. et,et al. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I , 1991, Science.
[42] R. Ploemacher,et al. Developments in modern hematology. , 1991, Bollettino della Societa italiana di biologia sperimentale.
[43] M. Shibuya,et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.
[44] P. Holt,et al. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. , 1980, Annals of the rheumatic diseases.